<DOC>
	<DOC>NCT00959569</DOC>
	<brief_summary>This large randomized double-blind clinical trial (esmolol vs placebo) will enroll patients undergoing cardiac surgery to study the additive cardiac protection of this therapeutic strategy.</brief_summary>
	<brief_title>Esmolol in Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Esmolol</mesh_term>
	<criteria>end diastolic diameter &gt;60 mm and an ejection fraction &lt;50% written informed consent age &gt;18 years previous unusual response to esmolol inclusion in other randomized studies esmolol administration in the previous 30 days emergency operation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>esmolol</keyword>
	<keyword>cardiac surgery</keyword>
	<keyword>cardiac anesthesia</keyword>
	<keyword>mortality</keyword>
	<keyword>beta blockers</keyword>
	<keyword>beta-blockers</keyword>
	<keyword>cardiac protection</keyword>
</DOC>